ABSTRACT
Acute phase proteins and markers of proteosynthetic activity reflect the clinical activity in Crohn's disease (CD). The impact of anti-tumor necrosis factor antibody (anti-TNF) therapy on serum levels of acute phase proteins and proteosynthetic markers was studied. Fourteen patients with active CD were treated with 5 mg per kg of anti-TNF in intravenous infusion. Clinical activity (assessed by Crohn's disease activity index - CDAI), alpha-1-acid glycoprotein, haptoglobin, cholinesterase and prealbumin were assessed before and in months 1 and 5 after treatment. A sustained decrease in CDAI was observed. This was accompanied by a significant decrease in alpha-1-acid glycoprotein and haptoglobin in month 1 (p=0.005 and p=0.01, respectively) while in month 5 the levels of both acute phase proteins rose significantly (p=0.003 for alpha-1-acid glycoprotein and p=0.02 for haptoglobin). Cholinesterase and prealbumin significantly increased in month 1 after the treatment (p=0.02 and p=0.0006, respectively), the increase was sustained in cholinesterase while prealbumin levels diminished in month 5. We conclude that the clinical improvement after anti-TNF therapy for CD is accompanied by changes of acute phase proteins and proteosynthetic markers. The assessment of these laboratory markers may be useful in the management of CD patients treated with anti-TNF.
Subject(s)
Antibodies, Monoclonal/therapeutic use , Crohn Disease/drug therapy , Gastrointestinal Agents/therapeutic use , Orosomucoid/metabolism , Tumor Necrosis Factor-alpha/immunology , Adult , Cholinesterases/blood , Crohn Disease/immunology , Crohn Disease/metabolism , Female , Haptoglobins/metabolism , Humans , Infliximab , Infusions, Intravenous , Male , Middle Aged , Prealbumin/metabolismABSTRACT
Disturbances of several humoral and cellular immune parameters are significantly increased in individuals exposed to chemical pollutants. Moreover, exacerbations of the latent Epstein-Barr virus (EBV) infection were more frequently observed in the chemically exposed group than in the control groups. A significant correlation was seen between EBV exacerbations and the increased number of eosinophils, T-lymphocyte rosette formation and the respiratory burst of polymorphonuclear blood cells. Possible links between hepatopathy due to xenobiotics exposition, immunological disturbances and EBV exacerbation are discussed, including a putative role of EBV-induced (autocrine) cytokines.
Subject(s)
Antibody Formation/drug effects , Chemical Industry , Chemical and Drug Induced Liver Injury , Environmental Pollutants/adverse effects , Herpesviridae Infections/immunology , Herpesvirus 4, Human/drug effects , Immunity, Cellular/drug effects , Occupational Diseases/chemically induced , Occupational Exposure , Oxidants/adverse effects , Virus Activation/drug effects , Xenobiotics/adverse effects , Antibodies, Viral/blood , Antigens, Viral/immunology , Cytokines/physiology , Electronics , Environmental Pollutants/pharmacology , Hepatitis C/immunology , Herpesvirus 4, Human/immunology , Herpesvirus 4, Human/physiology , Humans , Immunocompromised Host , Models, Immunological , Occupational Diseases/immunology , Oxidants/pharmacology , Oxidative Stress , Respiratory Burst , Retrospective Studies , Time Factors , Xenobiotics/pharmacologyABSTRACT
The authors investigated immunological parameters during treatment with risperidone and recorded a reduction of IgG and IgM after 24 weeks of treatment. With this finding corresponded a reduced IgG synthesis, but not IgM synthesis, investigated in vitro. It was thus revealed that risperidone does not exert an immunological effect. In the course of treatment changes of immune parameters were recorded which can be, however, explained by immunological aspects of the course of the disease. The role of the antagonist of 5HT receptors is very complicated and cannot be explained by a single mechanism.
Subject(s)
Antipsychotic Agents/pharmacology , Immunity/drug effects , Isoxazoles/pharmacology , Piperidines/pharmacology , Adult , Female , Humans , Male , Middle Aged , RisperidoneABSTRACT
In patients with the malignant tumor of bone (17 osteosarcomas, 8 Ewing tumors) longterm observations were made, and namely at the beginning of the disease, after the surgical removal of the tumor, during chemotherapy and in the terminal phase of the disease. The observations concentrated on the following selected immunology parameters: active lymphocytes T, lymphocytes T, lymphocytes B, large granular lymphocytes, IgG, IgA, IgM and circulating immune complexes. In non-treated patients prior to diagnosing the disease, reduction of active lymphocytes T was found out while the total lymphocytes T remained unchanged. However, no significant differences were found out between benign and malignant tumors. The surgical removal of the tumor results in the change in imunologic indicators, the increase of active lyphocytes T, lymphocytes T and the decrease in the circulating immune complexes. The change is of temporary nature, the subsequent deterioration is caused by both the progression of the disease and chemotherapy. The values of immunoglobulins and lymphocytes B fluctuated during the whole course of the disease in physiological levels. The observation of active lymphocytes T and lymphocytes T can be used for monitoring of the immunosuppression in cytostatic treatment. The levl of IgG is differentially diagnostically used to distinguish between the tumor and inflammatory processes.
